KUALA LUMPUR, Oct 9 (Bernama) – The government is committed to promote better public-private partnerships and focus to enhance primary healthcare in the country, said Health Minister Dr Dzulkefly Ahmad.
He said the vision was expressed during a courtesy call on outgoing World Health Organisation (WHO) Regional Director for the Western Pacific Dr Shin Young-Soo, which was held on the sidelines of the 69th Regional Committee Meeting for the Western Pacific, in Manila, Phillippines today.
"In that meeting, Dr Shin discussed about his observations on Malaysia during his stint in office, saying that "the Malaysia’s primary health care system is a treasure envied by other countries and that Malaysians need to be extremely grateful for having such and excellent healthcare system that is accessible to all," said Dr Dzulkefly in a statement made available to the media, here today.
Also present at the meeting was Director-General of Health Malaysia Datuk Dr Noor Hisham Abdullah.
The 69th WHO Regional Committee for the Western Pacific opened yesterday and ends on Oct 12.
Dr Dzulkefly said the Regional Director who is a South Korean national wished him (Dr Dzulkefly) to have the political will, under the leadership of Prime Minister Tun Dr Mahathir Mohamad, to ensure that Malaysia will invest more in rural areas in order to provide better health care services for the population there.
Additionally, Dr Dzulkefty said both he and Dr Noor Hisham also had an informal discussion with WHO Director-General, Dr Tedros Adhanom.
During the brief discussion, Dr Dzulkefly said he had expressed Malaysia's commitment to continue to support the WHO Global Service Centre in Cyberjaya as a form of in-kind contribution to WHO and that Malaysia looked forward to further collaborate with WHO in various activities.
By Durratul Ain Ahmad Fuad
KUALA LUMPUR (Bernama) – A potentially effective treatment for patients with relapsed and refractory acute lymphoblastic leukaemia (ALL) is in the works.
ALL is a type of blood cancer in which the bone marrow makes too many lymphocytes, a type of white blood cell.
Universiti Kebangsaan Malaysia’s teaching facility Hospital Canselor Tuanku Muhriz (HCTM) is collaborating with Plutonet Sdn Bhd on a study and clinical trial involving the Chimeric Antigen Receptor-T Cell (CAR-T) therapy, a revolutionary treatment found to be effective for ALL patients who cannot be treated with chemotherapy or are immune to it.read more ››
UMSC: Pain Management